Will Donald Trump’s 100% drug tariffs impact India’s $27 billion pharma exports?
US President Donald Trump has announced 100% tariffs on branded and patented drug imports since October 2025. Experts say that Indian pharmaceutical exports may have a limited impact because generics are dominant. The details are here.
Donald Trump with Narendra Modi. (File picture)
As explained by US President Donald Trump, how will the Indian pharmaceutical industry be affected by 100 percent tariffs on branded and patented drugs? The reality of the social media platform announced tariffs about products such as branded or patented drugs that are not made in the United States and imported to the country. Authorized, such products will encounter 100 percent of tariffs from 1 October 2025 onwards. However, Trump added that companies that build production units in the US will be exempted from this tax. The president announced that US companies will be exempted from the “groundbreaking” and/or “or” or “or” or “or” or “production stage. Authority, the construction business before the previously applied additional tariff will not have to pay the additional tariff, he added.
India dominates the generic pharmaceutical market
How will it affect Indian pharmaceutical companies? According to the Indian Equity Foundation (PPI), India has most compatible companies with plants outside the USA (USFDA). 20 Global Generic Company Eight from India and their share in the United States more than 55% of exports. India is the largest vaccine exporter, the Health Organization (WHO) purchases approximately 65-70% of world vaccine requirements.
How much does India export?
India exported drugs and drugs worth 27.82 billion dollars in 2024. It was worth 25.4 billion dollars in 2023 and 24.59 billion dollars in 2022. In 2021, India exported drugs and drugs worth $ 24,44 billion. The US is an important market for Indian drugs and pharmaceutical products with exports worth $ 8.7 billion in 2024. However, formulations and biologicals constituted most of India’s exports by 78.94 percent. These were followed by medication and casting drugs with a share of 16.21%.
Will Trump’s 100% tariffs affect India?
India may not be much affected as most of the exports do not enter the categories where Trump does not enter 100 percent tariffs. Reacting to Trump’s announcement, Pharmaxcil President Namit Joshi said in a statement, “the 100% tariff proposed on branded and patented drug imports, simple generic and most of the major Indian companies have an immediate impact on the US manufactures and more people have examined the purchase of more people.
However, he warned that it is cautious for being ready for future policy changes and creating risk-authorization strategies. He also advised Indian companies to benefit from cost efficiency in pouring drugs and APIs and invest in new generation opportunities such as complex generic, peptides, biobenzer and CAR-T therapies.
FAQ
Q1: How much does India export medicines and medicines?
Ans: India exported drugs and drugs worth 27.82 billion dollars in 2024. It was $ 25.4 billion in 2023 and 24.59 billion dollars in 2022. In 2021, India exported drugs and drugs worth $ 24,44 billion. The United States is an important market for Indian drugs and pharmaceutical products with exports of $ 8.7 billion in 2024.
Q2: How will Indian drug and pharmaceutical companies affected by US tariffs?
Ans: Most of the exports are not affected by India as they do not enter the categories where Trump is applying 100 percent tariffs. Formulations and biologicals, with a share of 78.94 percent, formed a large part of India’s exports.
Summary
As explained by US President Donald Trump, how will the Indian pharmaceutical industry be affected by 100 percent tariffs on branded and patented drugs? The reality of the social media platform announced tariffs about products such as branded or patented drugs that are not made in the United States and imported to the country. Authorized, such products will encounter 100 percent of tariffs from 1 October 2025 onwards. However, Trump added that companies that build production units in the US will be exempted from this tax. The president announced that US companies will be exempted from the “groundbreaking” and/or “or” or “or” or “or” or “production stage. Authorized, the construction business before the previously applied additional tariff will not have to pay the additional tariff, he added.
